Acta Psychiatrica Scandinavica
© John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Edited By: Povl Munk-Jørgensen
Impact Factor: 5.605
ISI Journal Citation Reports © Ranking: 2014: 12/133 (Psychiatry (Social Science)); 17/140 (Psychiatry)
Online ISSN: 1600-0447
Relevant Documents: Colour Work Agreement Form.
Acta Psychiatrica Scandinavica uses ScholarOne Manuscripts, the electronic editorial office. To submit a manuscript, please follow the instructions below:
Please go to the Acta Psychiatrica Scandinavica ScholarOne Manuscripts. Log-in or click the 'Create Account' option if you are a first-time user of ScholarOne Manuscripts.
If you are creating a new account, enter your name and e-mail information. Your e-mail information is very important.
Enter your institution and address information as appropriate.
Enter a user ID and password of your choice, and then select your area of expertise.
Confirmation of receipt will be sent to the corresponding author.
If you have an account but have forgotten your log-in details, go to 'Password Help' and enter your email address. The system will send you an automatic reminder.
Log-in and select 'Author Center'
Submitting Your Manuscript*
After you have logged-in, click the 'Submit a Manuscript' link in the menu bar. Follow the prompts and answer the questions as appropriate.
Upload your files as instructed. Review your submission before sending to the Journal. Click 'Submit'. You may suspend a submission at any phase before clicking the 'Submit' button. After submission you will receive a confirmation e-mail. The Journal will inform you once a decision has been made on your manuscript.
Acta Psychiatrica Scandinavica employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.
Getting Help with Submissions
You can contact ScholarOne Manuscripts' online support system at http://mcv3support.custhelp.com. Telephone support is available 24 hours a day, 5 days a week through the US ScholarOne Support Office on: +1 434 817 2040, ext 167.
If you do not have internet access or cannot submit online, the Editorial Office can assist you. Please contact the Editorial Office by telephone: +44 (0)845 834 0370 or by e-mail: ActaPsych.email@example.com.
Authors submitting a paper do so on the understanding that the work has not been published before, is not being considered for publication elsewhere and has been read and approved by all authors.
The authors are requested to pay close attention to the following:
Consult a current issue of the Journal for style and format. The text should be in double-spacing with broad margins. Review articles/meta-analyses, clinical overview articles and original articles all follow the same concept:
A concise, informative title (max 15 words; abbreviations, acronyms, colon, semicolon or the like are not allowed), the authors' names, the names in English of departments and institutions to be attributed, and their city and country of location. Please also include a running title with a maximum of 50 characters (letters and spaces). Name, telephone number, fax number, e-mail address and full postal address of the corresponding author should be stated.
Abstract not exceeding 200 words with the following structure: Objective, Method, Results, and Conclusion (the main part of the Abstract is devoted to Results). - Indication of 3 - 5 keywords in strict accordance with Medical Subject Headings.
For original articles specifically:
Significant Outcomes. Provide up to 3 Significant Outcomes encapsulating the 'take-home messages' of the article, and identify the main issues addressed with particular emphasis on clinical and/or scientific significance. The Significant Outcomes are to be presented succinctly (1 max 2 sentences each), in tabulated form, and logically emerge from the conclusions of the paper (without repeating). However, they must not be dogmatic, raise new issues or pose further questions.
Limitations. In addition, each original article must cite up to 3 noteworthy Limitations. These should inform the reader about potential weaknesses, for instance in aspects of study design, methodology, analyses, the wider generalizability, or the wider application of findings.
The Significant Outcomes and the Limitations are placed immediately below the Abstract/Keywords.
For review articles/meta-analyses specifically:
Summations. Provide up to 3 significant Summations encapsulating the 'take-home messages' of the paper, and identify the main issues addressed with particular emphasis on their clinical and/or scientific significance. The Summations should be presented succinctly (1 max 2 sentences each), in tabulated form, and logically emerge from the conclusions of the paper (without repeating). However, they must not be dogmatic, raise new issues or pose further questions.
Considarations. In addition, each review article must cite up to 3 noteworthy Considerations in which authors essentially criticise the summations and include any caveats or limitations either of the review process or its conclusions.
The Summations and Considerations are placed immediately below the Abstract/Keywords.
For clinical overview articles specifically:
Clinical Recommendations. Provide up to 3 significant Clinical Recommendations. Present them succinctly (1 max 2 sentences each), in tabulated form, and logically emerge from the conclusions of the article (without repeating). However, they must not be dogmatic, raise new issues or pose further questions, and authors should avoid jumping to conclusions.
Additional Comments. In addition, each clinical overview article must provide up to 3 Additional Comments in which authors cite caveats/limitations and attempt to balance their recommendations by including for instance alternative contemporary views/recommendations.
The Clinical Recommendations and Additional Comments are placed immediately below the Abstract/Keywords.
One to two pages concluded by the subtitle Aims of the Study (3 to 5 lines without literature references and abbreviations).
A thorough Material and methods section. It should be possible to read every article by itself. The author cannot refer to design, method and material described in previously published articles.
Results. Clear and short avoiding double documentation to tables/figures.
Acta Psychiatrica Scandinavica articles do not have a conclusion section. If the authors find it necessary, they may include a concluding remark of maximum 5 lines as the final part of the Discussion.
Should include grants, sponsorships and other support to the study. Some authors may wish to thank other collaborators apart from the authors. It is stressed that only a very few people can be listed. It is the responsibility of the author to obtain written permission from the persons mentioned.
Declaration of Interest:
Must be given if the study in any way involves pharmaceutical companies or other private or public enterprises. Each author must declare him/herself in general and not only in relation to the present study. If the study in any way investigates pharmaceutical compounds, the Declaration of Interest must contain information about by whom and which institutions the statistical analyses were performed and an e-mail address where to obtain the protocol. Clinical studies must be registered in online clinical databases. Please state date for registration and registration number.
Tables and figures:
Must include legends. A maximum of 5 tables/figures can be included. Figures are given priority. Colour prints are welcomed, but please notice that authors must cover the additional production cost.
Letters to the Editor are welcomed to the Acta Psychiatrica Scandinavica debate section, in particular if they relate to ongoing debates or comment on recent publications in the Journal. A maximum of 5 references can be included in papers published in the Debate Section.
Abbreviations and symbols
For abbreviations and symbols use Units, Symbols and Abbreviations for Authors and Editors in Medicine Related Sciences, Sixth Edition. Edited by D.N. Baron and M McKenzie Clarke. ISBN: 9781853156243, Paperback, April, 2008. All terms or abbreviations should be fully explained at first mention. All units should be metric. Use no Roman numerals. Abbreviations are not allowed in titles, headings and “Aims of the Study”.
Should be kept to the pertinent minimum and numbered consecutively in the order in which they appear in the text in accordance with the Vancouver System. Identify references in text, tables, and legends by Arabic numerals (in parentheses). References cited only in tables or figure legends should be numbered in accordance with a sequence established by the first identification of that figure or table in the text. Use the style of the examples below, which are based on Index Medicus. Abstracts cannot be used as references, unless published in an indexed scientific journal. Include manuscripts accepted, but not published; designate the abbreviated title of the journal followed by (in press). Papers published electronically, not yet hard copy publication should be identified by their DOI-number. Information from manuscripts not yet accepted should be cited in the text as personal communication. References must be verified by the authors against the original documents. Titles of journals should be abbreviated in accordance with Index Medicus. Examples:
Standard journal article: List all authors when 6 or fewer. When there are 7 or more, list only the first 3 authors and add "et al".
MAZZONCINI R, DONOGHUE K, HART J et al. Illicit substance use and its correlates in first episode psychosis. Acta Psychiatr Scand 2010;121:351-358
Chapter in book:
ISMAIL K. Unraveling the pathogenesis of the depression-diabetes link. In KATON W, MAJ, M, SATORIUS N, eds. Depression and diabetes, Wiley-Blackwell, UK, 2010.
All figures/tables should clarify the text and their number be kept to a minimum and not exceed 5 in total. Avoid data overload. Details must be large enough to retain their clarity after reduction in size. Illustrations should be planned to fit the proportions of the printed page. Colour illustrations are welcomed. Authors must cover the production cost of colour illustrations. Download the publisher's Colour Work Agreement Form.
Copyright Transfer Agreement
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:
For authors choosing OnlineOpen If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
- Creative Commons Attribution Non-Commercial License OAA
- Creative Commons Attribution Non-Commercial -NoDerivs License OAA
If you select the OnlineOpen option and your research is funded by certain funders [e.g. The Wellcome Trust and members of the Research Councils UK (RCUK) or the Austrian Science Fund (FWF)] you will be given the opportunity to publish your article under a CC-BY license supporting you in complying your Funder requirements . For more information on this policy and the Journal’s compliant self-archiving policy please visit:http://www.wiley.com/go/funderstatement.
For RCUK, Wellcome Trust, FWF authors click on the link below to preview the terms and conditions of this license:
- Creative Commons Attribution License OAA
The work shall not be published elsewhere in any language without the written consent of the publisher. Articles published in this journal are protected by copyright, which covers translation rights and the exclusive right to reproduce and distribute all of the articles printed in the journal. No material published in the journal may be stored on microfilm, video-cassettes, in electronic databases or the like without the written permission of the publisher.
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive.
All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
Supplementary material online
Acta Psychiatrica Scandinavica does not publish supplementary or supporting material online.
Free access to the final PDF offprint or your article will be available via Author Services only. Please therefore sign up for author services if you would like to access your article PDF offprint and enjoy the many other benefits the service offers. Offprint Request: Free access to the final PDF offprint or your article will be available via Author Services only. Paper offprints of your article may be ordered online. Please visit http://offprint.cosprinters.com/blackwell. Ensure that you type information in all of the required fields. If you have queries about offprints please email: firstname.lastname@example.org
Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production so they don't need to contact the production editor to check on progress. Visit Author Services for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Papers to be published as supplements should be submitted to the editor after previous agreement with the editor and Wiley-Blackwell on content and finances. Authors should follow the instructions given above. The quality of language and scientific content must meet the standards of the journal. Material published in supplements will undergo regular review by the guest editor, an expert reviewer and the editor. With regard to supplements, it is the policy of Wiley-Blackwell to acknowledge sponsorship. All cost relating to preparation and publication of a supplement must be covered by the author/sponsor. Information about distribution, printing costs, etc. can be obtained from Mike Weetman. Email: email@example.com.
Referrals to the Open Access Journals Brain and Behavior and Clinical Case Reports
Authors of high quality papers that Acta cannot offer to publish, perhaps due to scope or space, may be offered the option to have their manuscript and peer review reports forwarded for consideration by the editor of either of Wiley’s Open Access Journals Brain and Behavior or Clinical Case Reports. If the author accepts, then the manuscript and peer review reports, if available, will be picked up by the Open Access Journal's editor. Where the manuscript is forwarded with peer review reports the time spent on the first round of reviews at Acta Psychiatrica Scandinavica will not have to be spent again, as the editor of Brain & Behavior or Clinical Case Reports will usually be able to make his first decision (reject, revise or accept) based on those reports. Articles that are eventually accepted by the Brain and Behavior or Clinical Case Reports, perhaps after revision, will typically be published within 15 days of acceptance. The Editor of the Open Access Journal will accept submissions that report well-conducted research which reaches the standard acceptable for publication. Brain and Behavior and Clinical Case Reports are Wiley Open Access journals and article publication fees apply.
The Publisher and the Editor cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; the views and opinions expressed do not necessarily reflect those of the Publisher and the Editor.